These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 15639687)
21. The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials. Wang SZ; Hu JT; Zhang C; Zhou W; Chen XF; Jiang LY; Tang ZH BMJ Open; 2014 Jun; 4(6):e004744. PubMed ID: 24961714 [TBL] [Abstract][Full Text] [Related]
31. Daptomycin: a review 4 years after first approval. Sauermann R; Rothenburger M; Graninger W; Joukhadar C Pharmacology; 2008; 81(2):79-91. PubMed ID: 17940348 [TBL] [Abstract][Full Text] [Related]
33. A retrospective analysis of adverse events among patients receiving daptomycin versus vancomycin during outpatient parenteral antimicrobial therapy. Schrank GM; Wright SB; Branch-Elliman W; LaSalvia MT Infect Control Hosp Epidemiol; 2018 Aug; 39(8):947-954. PubMed ID: 29893658 [TBL] [Abstract][Full Text] [Related]
34. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. Steenbergen JN; Alder J; Thorne GM; Tally FP J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644 [TBL] [Abstract][Full Text] [Related]
35. Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia. Arrieta AC; Bradley JS; Popejoy MW; Bensaci M; Grandhi A; Bokesch P; Glasser C; Du L; Patino H; Kartsonis NA Pediatr Infect Dis J; 2018 Sep; 37(9):893-900. PubMed ID: 29406465 [TBL] [Abstract][Full Text] [Related]
36. Daptomycin in bone and joint infections: a review of the literature. Rice DA; Mendez-Vigo L Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis. Kullar R; McClellan I; Geriak M; Sakoulas G Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897 [TBL] [Abstract][Full Text] [Related]
38. Daptomycin, a lipopeptide antibiotic in clinical practice. Weis F; Beiras-Fernandez A; Schelling G Curr Opin Investig Drugs; 2008 Aug; 9(8):879-84. PubMed ID: 18666036 [TBL] [Abstract][Full Text] [Related]
39. [Daptomycin for the treatment of Gram-positive microorganisms in the critically-ill patient]. Alvarez-Lerma F; Gracia-Arnillas MP Med Clin (Barc); 2010 Dec; 135 Suppl 3():29-35. PubMed ID: 21477702 [TBL] [Abstract][Full Text] [Related]
40. Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections. Abdel-Rahman SM; Benziger DP; Jacobs RF; Jafri HS; Hong EF; Kearns GL Pediatr Infect Dis J; 2008 Apr; 27(4):330-4. PubMed ID: 18316988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]